Dxcover
9 known investors
Find your way into Dxcover
Dxcover provides a platform for rapid development of liquid biopsies to detect cancer and other diseases.
Investors · 9
Eos Advisory✓ verifiedSt Andrews
Scottish Enterprise✓ verifiedGlasgow
Alba EquityAberdeen
British Business BankreportedSheffield
Maven Capital Partnersreported · 2 sourcesUK · $32K – $25M
Also in the syndicate · 4
Macmillan Cancer SupportNorcliffe CapitalleadSIS VenturesleadUniversity of Strathclydelead
Funding
SEC filings, press & company announcements$6.2M disclosed across 1 of 2 rounds · 2023–2025
- $6.2MraisedFeb 2025 · 4 sources
Eos Advisory (lead), Norcliffe Capital (lead), SIS Ventures (lead), University of Strathclyde (lead), British Business Bank, Macmillan Cancer Support, Maven Capital Partners
Source ↗ - Undisclosed amountSeries AFeb 2023Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Competitors · 7
by search overlapEarlydx5 shared keywordsEarlyDx develops non-invasive liquid biopsy tests aimed at early cancer detection and precision medicine. The company positions its tests as accurate and affordable diagnostics.
Foresight Diagnostics3 shared keywordsForesight Diagnostics develops ultra-sensitive molecular diagnostic tests that combine genomics and bioinformatics to detect minimal residual disease and circulating tumor DNA across multiple cancer types. Its offerings support oncology drug development, clinical trials, and patient care for academic and biopharma partners.
Digital Diagnostics3 shared keywordsDigital Diagnostics is a healthcare technology company that builds AI systems to diagnose disease by analyzing medical images. Its flagship system diagnoses diabetes-related eye disease at the point of care without requiring a physician to review the images, serving primary and specialty care providers.
Labcorp3 shared keywordsLabCorp provides diagnostic testing services and clinical trial recruitment solutions that connect patient insights to drug development for healthcare providers.
Smarter Dx3 shared keywordsSmarterDx provides a clinical AI platform that helps hospitals and health systems improve documentation, coding, and revenue cycle management by accurately capturing the complexity of patient care. The platform assists health systems in recovering revenue, improving quality scores, and streamlining workflows across the revenue cycle.
Pinkdx3 shared keywordsPinkDx is a diagnostics company developing tests, led by a leadership team spanning scientific, medical, and business functions.
CareDx3 shared keywordsCareDx provides innovative solutions and diagnostic tools for transplant patients throughout their pre- and post-transplant journey to improve outcomes and equity in organ transplantation.
Companies competing with Dxcover for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Dxcover do?
- Dxcover provides a platform for rapid development of liquid biopsies to detect cancer and other diseases.
- Who are Dxcover's investors?
- Dxcover's investors include Eos Advisory, Scottish Enterprise, Alba Equity, British Business Bank, Maven Capital Partners.
- How much funding has Dxcover raised?
- Dxcover has disclosed $6.2M raised across 1 of its 2 known rounds.